Victory Capital Management Inc. Raises Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Victory Capital Management Inc. increased its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 402.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 179,049 shares of the company’s stock after purchasing an additional 143,446 shares during the quarter. Victory Capital Management Inc. owned approximately 0.15% of Privia Health Group worth $3,260,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC lifted its holdings in shares of Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares during the last quarter. Peregrine Capital Management LLC boosted its holdings in Privia Health Group by 11.5% in the 2nd quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock worth $5,461,000 after buying an additional 32,311 shares during the last quarter. BlackBarn Capital Partners LP boosted its holdings in Privia Health Group by 100.0% in the 2nd quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock worth $6,952,000 after buying an additional 200,000 shares during the last quarter. Millennium Management LLC boosted its holdings in shares of Privia Health Group by 2,994.2% during the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after purchasing an additional 1,101,730 shares during the last quarter. Finally, GSA Capital Partners LLP boosted its holdings in shares of Privia Health Group by 228.1% during the 3rd quarter. GSA Capital Partners LLP now owns 50,975 shares of the company’s stock worth $928,000 after purchasing an additional 35,439 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. The trade was a 35.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 14.20% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have recently commented on PRVA. Robert W. Baird lifted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. Royal Bank of Canada reiterated an “outperform” rating and set a $28.00 target price on shares of Privia Health Group in a research note on Wednesday, August 14th. KeyCorp assumed coverage on shares of Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective for the company. Barclays upped their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Finally, Truist Financial raised their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $25.07.

Privia Health Group Stock Performance

PRVA stock opened at $21.56 on Friday. The stock has a market capitalization of $2.59 billion, a P/E ratio of 215.62, a PEG ratio of 5.26 and a beta of 0.76. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.30. The company has a 50 day moving average price of $18.96 and a two-hundred day moving average price of $18.57.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.